Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0002129331-26-000003
Filing Date
2026-06-10
Accepted
2026-06-10 12:21:19
Documents
1
Period of Report
2018-12-16

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT primary_doc.html 4  
1 PRIMARY DOCUMENT primary_doc.xml 4 3786
  Complete submission text file 0002129331-26-000003.txt   5191
Mailing Address 685 U.S. HIGHWAY ONE, 2ND FLOOR NORTH BRUNSWICK NJ 08902
Business Address 685 U.S. HIGHWAY ONE, 2ND FLOOR NORTH BRUNSWICK NJ 08902 848-230-7430
Adlai Nortye Ltd. (Issuer) CIK: 0001944552 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 124 OLD TURNPIKE RD CALIFON NJ 07830
Business Address
Ji Ping (Reporting) CIK: 0002129331 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-41773 | Film No.: 261078907